Chromophobe renal cell carcinoma, renal cell carcinoma, tubular cell carcinoma, lung adenocarcinoma, and lung squamous carcinoma showed lower ACSL4 expression, while cholangiocarcinoma, colon cancer, and hepatic cell carcinoma showed higher expression level. This evidence concerns the gene ACSL4 and hereditary clear cell renal cell carcinoma.